Prescription for a healthier world
PATH’s Drug Development program is working to develop and ensure availability and accessibility of safe and effective new medicines for diseases disproportionately affecting people in developing countries. By combining entrepreneurial energy, pharmaceutical expertise, and an innovative product development partnership model, we challenge the assumption that pharmaceutical research and development is too expensive to create the new medicines that the developing world desperately needs. Find out more »
Partnership advances drug formulation that could help prevent HIV infection
A new licensing agreement with pharmaceutical company Janssen R&D Ireland to develop an injectable form of the medicine rilpivirine could provide a new tool in the fight to stop the spread of HIV. Read the announcement »
Sign up for our e-newsletter
Our e-newsletter, A Healthy Dose, gives advocates, policymakers, government and agency leaders, and anyone interested in global health a quarterly update on our work. Each issue features reports from the field, news on the latest clinical trial milestones, and resources in nonprofit drug development. Sign up now »
Banner photo: Jonathan Torgovnik.